Serato, Charlene P.
HRN: 22-20-39 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
10/05/2023
CO-AMOXICLAV 625MG (TAB)
10/05/2023
10/11/2023
PO
1 Tab
BID
S/p Perineorrhaphy
Waiting Final Action
Indication: Prophylaxis Type of Infection: Skin & Soft Tissue Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes